How does milrinone help in the management of cardiogenic shock in Takotsubo cardiomyopathy (TTC)?

Label:chem

Topic
Milrinone is a non-catecholaminergic inotropic agent that acts by increasing cyclic AMP levels in cardiac myocytes, leading to increased contractility without the adverse effects associated with catecholamines. It is preferred in the management of cardiogenic shock in TTC due to the condition's pathophysiology involving catecholamine excess.
Answer
Milrinone was used to support the patient's circulatory function in this case of TTC-related cardiogenic shock. It improved hemodynamics and allowed for the discontinuation of norepinephrine, contributing to the patient's recovery.
Return to Home Chemical List
Knowledge you may be interested in
What role does tetrahydrocannabinol (THC) play in the development of Takotsubo cardiomyopathy (TTC)? How effective is the combination of intraarterial Milrinone and Nimodipine in treating severe refractory cerebral vasospasm (VSP)? What is the role of Nimodipine in treating severe refractory cerebral vasospasm (VSP) following aneurysmal subarachnoid hemorrhage (aSAH)? What is the role of Milrinone in treating severe refractory cerebral vasospasm (VSP) following aneurysmal subarachnoid hemorrhage (aSAH)? How does Milrinone potentially contribute to cancer therapy? What is the potential role of Terbutaline in cancer therapy? How do different silane coupling agents affect the shear-thinning behavior of Fe3O4/CNT silicone oil-based magnetic liquids? What is the effect of different silane coupling agents on the magneto-viscous effect of Fe3O4/CNT silicone oil-based magnetic liquids? How does the molecular structure of silane coupling agents influence the viscosity-temperature properties of Fe3O4/CNT silicone oil-based magnetic liquids? What is the role of silane coupling agents in modifying the rheological properties of Fe3O4/CNT silicone oil-based magnetic liquids? What is the role of milrinone in the management of cardiogenic shock? What is the role of dobutamine in the management of cardiogenic shock? How does renal function impact the efficacy of milrinone compared to dobutamine in cardiogenic shock? What are the implications of acute kidney injury (AKI) on the treatment effect of milrinone compared to dobutamine? What is the role of hcast 3-25 in the regulation of calpain-1 activity? How does hcast 3-25 interact with calpain-1 in the absence of Ca2+? What is the effect of hcast 3-25 on calpain-1 activity in the presence of inhibitory calpastatins? How does Angiotensin II (AngII) affect podocyte autophagy in hypertension-induced kidney injury? What is the role of calpastatin in preventing Angiotensin II-mediated podocyte injury? How does the deletion of Atg5 in podocytes affect the progression of Angiotensin II-induced kidney injury?